ANTABIO is a series b startup based in France. 1 investor tracked.
Antabio is a company founded in 2014 headquartered in France. Brouky records 3 investors associated with the company.
Antabio is a biopharmaceutical company focused on developing novel antibacterial drugs. Their primary goal is to combat life-threatening infections caused by antibiotic-resistant bacteria.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.